A synthetic virus-like particle streptococcal vaccine candidate using B-cell epitopes from the proline-rich region of pneumococcal surface protein A

Vaccines

Volumn 3, Issue 4, 2015, Pages 850-874

  Tamborrini, Marco ^a,b   Geib, Nina ^c   Marrero Nodarse, Aniebrys ^c   Jud, Maja ^a,b   Hauser, Julia ^a,b   Aho, Celestine ^a,b   Lamelas, Araceli ^a,b   Zuniga, Armando ^c   Pluschke, Gerd ^a,b   Ghasparian, Arin ^c   Robinson, John A ^d  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Virometix AG   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Peptide; PspA; Streptococcus; Synthetic virus like particle; Vaccine

Indexed keywords

EPITOPE; LIPOPEPTIDE; MONOCLONAL ANTIBODY; PROLINE; PROTEIN A; STREPTOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ANIMAL CELL; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOGENICITY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; VIRUS LIKE AGENT;

EID: 85016918783     PISSN: None     EISSN: 2076393X     Source Type: Journal    
DOI: 10.3390/vaccines3040850     Document Type: Article

References (46)

1. Blasi, F.; Mantero, M.; Santus, P.; Tarsia, P. Understanding the burden of pneumococcal disease in adults. Clin. Microbiol. Infect. 2012, 18, 7-14.
2. Drijkoningen, J.J.C.; Rohde, G.G.U. Pneumococcal infection in adults: Burden of disease. Clin. Microbiol. Infect. 2014, 20, 45-51.
3. O'Brien, K.L.; Wolfson, L.J.; Watt, J.P.; Henkle, E.; Deloria-Knoll, M.; McCall, N.; Lee, E.; Mulholland, K.; Levine, O.S.; Cherian, T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: Global estimates. Lancet 2009, 374, 893-902.
4. Feldman, C.; Anderson, R. Review: Current and new generation pneumococcal vaccines. J. Infect. 2014, 69, 309-325.
5. Tarahomjoo, S. Recent approaches in vaccine development against Streptococcus pneumoniae. J. Mol. Microbiol. Biotechnol. 2014, 24, 215-227.
6. Paradiso, P.R. Pneumococcal conjugate vaccine for adults: A new paradigm. Clin. Infect. Dis. 2012, 55, 259-264.
7. Poolman, J.T.; Peeters, C.; van den Dobbelsteen, G. The history of pneumococcal conjugate vaccine development: Dose selection. Exp. Rev. Vaccines 2013, 12, 1379-1394.
8. Pilishvili, T.; Lexau, C.; Farley, M.M.; Hadler, J.; Harrison, L.H.; Bennett, N.M.; Reingold, A.; Thomas, A.; Schaffner, W.; Craig, A.S.; et al. Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine. J. Infect. Dis. 2010, 201, 32-41.
9. Gladstone, R.A.; Jefferies, J.M.; Faust, S.N.; Clarke, S.C. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults. Exp. Rev. Vaccines 2012, 11, 889-902.
10. Ginsburg, A.S.; Alderson, M.R. New conjugate vaccines for the prevention of pneumococcal disease in developing countries. Drugs Today 2011, 47, 207-214.
11. Brandau, D.T.; Jones, L.S.; Wiethoff, C.M.; Rexroad, J.; Middaugh, C.R. Thermal stability of vaccines. J. Pharm. Sci. 2003, 92, 218-231.
12. Dagan, R.; Goldblatt, D.; Maleckar, J.R.; Yaich, M.; Eskola, J. Reduction of Antibody Response to an 11-Valent Pneumococcal Vaccine Coadministered with a Vaccine Containing Acellular Pertussis Components. Infect. Immun. 2004, 72, 5383-5391.
13. Singleton, R.J.; Hennessy, T.W.; Bulkow, L.R.; Hammitt, L.L.; Zulz, T.; Hurlburt, D.A.; Butler, J.C.; Rudolph, K.; Parkinson, A. INvasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. J. Am. Med. Assoc. 2007, 297, 1784-1792.
14. Weinberger, D.M.; Malley, R.; Lipsitch, M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011, 378, 1962-1973.
15. Wyres, K.L.; Lambertsen, L.M.; Croucher, N.J.; McGee, L.; von Gottberg, A.; Linares, J.; Jacobs, M.R.; Kristinsson, K.G.; Beall, B.W.; Klugman, K.P.; et al. Pneumococcal Capsular Switching: A Historical Perspective. J. Infect. Dis. 2013, 207, 439-449.
16. Miyaji, E.N.; Oliveira, M.L.S.; Carvalho, E.; Ho, P.L. Serotype-independent pneumococcal vaccines. Cell. Mol. Life Sci. 2013, 70, 3303-3326.
17. Ginsburg, A.S.; Nahm, M.H.; Khambaty, F.M.; Alderson, M.R. Issues and challenges in the development of pneumococcal protein vaccines. Expert Rev. Vaccines 2012, 11, 279-285.
18. Tobin, G.J.; Trujillo, J.D.; Bushnell, R.V.; Lin, G.; Chaudhuri, A.R.; Long, J.; Barrera, J.; Pena, L.; Grubman, M.J.; Nara, P.L. Deceptive imprinting and immune refocusing in vaccine design. Vaccine 2008, 26, 6189-6199.
19. Boato, F.; Thomas, R.M.; Ghasparian, A.; Freund-Renard, A.; Moehle, K.; Robinson, J.A. Synthetic virus-like particles from self-assembling coiled-coil lipopeptides and their use in antigen display to the immune system. Angew. Chem. Int. Ed. 2007, 46, 9015-9018.
20. Ghasparian, A.; Riedel, T.; Koomullil, J.; Moehle, K.; Gorba, C.; Svergun, D.I.; Perriman, A.W.; Mann, S.; Tamborrini, M.; Pluschke, G.; et al. Engineered Synthetic Virus-Like Particles and Their Use in Vaccine Delivery. Chembiochem 2011, 12, 100-109.
21. Perriman, A.W.; Williams, D.S.; Jackson, A.J.; Grillo, I.; Koomullil, J.M.; Ghasparian, A.; Robinson, J.A.; Mann, S. Synthetic viruslike particles and hybrid constructs based on lipopeptide self-assembly. Small 2010, 6, 1191-1196.
22. Riedel, T.; Ghasparian, A.; Moehle, K.; Rusert, P.; Trkola, A.; Robinson, J.A. Synthetic Virus-Like Particles and Conformationally Constrained Peptidomimetics in Vaccine Design. Chembiochem 2011, 12, 2829-2836.
23. Effio, C.L.; Hubbuch, J. Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles. Biotechnol. J. 2015, 10, 715-727.
24. Rodriguez-Limas, W.A.; Sekar, K.; Tyo, K.E.J. Virus-like particles: The future of microbial factories and cell-free systems as platforms for vaccine development. Curr. Opin. Biotechnol. 2013, 24, 1089-1093.
25. Zhang, X.; Xin, L.; Li, S.W.; Fang, M.J.; Zhang, J.; Xia, N.S.; Zhao, Q.J. Lessons learned from successful human vaccines: Delineating key epitopes by dissecting the capsid proteins. Hum. Vaccines Immunother. 2015, 11, 1277-1292.
26. Mukerji, R.; Mirza, S.; Roche, A.M.; Widener, R.W.; Croney, C.M.; Rhee, D.-.K.; Weiser, J.N.; Szalai, A.J.; Briles, D.E. Pneumococcal Surface Protein A Inhibits Complement Deposition on the Pneumococcal Surface by Competing with the Binding of C-Reactive Protein to Cell-Surface Phosphocholine. J. Immunol. 2012, 189, 5327-5335.
27. Ren, B.; Li, J.; Genschmer, K.; Hollingshead, S.K.; Briles, D.E. The Absence of PspA or Presence of Antibody to PspA Facilitates the Complement-Dependent Phagocytosis of Pneumococci In Vitro. Clin. Vaccines Immunol. 2012, 19, 1574-1582.
28. Shaper, M.; Wilson, L.; Benjamin, W.H.; Novak, J.; Barnes, S.; Hollingshead, S.K.; Briles, D.E. Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin. Infect. Immun. 2011, 79, 2440-2450.
29. Shaper, M.; Hollingshead, S.K.; Benjamin, W.H.; Briles, D.E. PspA Protects Streptococcus pneumoniae from Killing by Apolactoferrin, and Antibody to PspA Enhances Killing of Pneumococci by Apolactoferrin. Infect. Immun. 2004, 72, 5031-5040.
30. Hollingshead, S.K.; Becker, R.; Briles, D.E. Diversity of PspA: Mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect. Immun. 2000, 68, 5889-5900.
31. Daniels, C.C.; Coan, P.; King, J.; Hale, J.; Benton, K.A.; Briles, D.E.; Hollingshead, S.K. The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to All pneumococci and elicits antibody-mediated protection against sepsis. Infect. Immun. 2010, 78, 2163-2172.
32. Brooks-Walter, A.; Briles, D.E.; Hollingshead, S.K. The pspC Gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive Antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect. Immun. 1999, 67, 6533-6542.
33. Melin, M.; Coan, P.; Hollingshead, S. Development of cross-reactive antibodies to the proline-rich region of pneumococcal surface protein A in children. Vaccine 2012, 30, 7157-7160.
34. Atherton, E.; Sheppard, R.C. Solid Phase Peptide Synthesis A Practical Approach; Oxford University Press: Oxford, UK, 1989.
35. Pai, R.; Gertz, R.E.; Beall, B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J. Clin. Microbiol. 2006, 44, 124-131.
36. Goulart, C.; Darrieux, M.; Rodriguez, D.; Pimenta, F.C.; Brandileone, M.C.C.; de Andrade, A.L.S.S.; Leite, L.C.C. Selection of family 1 PspA molecules capable of inducing broad-ranging cross-reactivity by complement deposition and opsonophagocytosis by murine peritoneal cells. Vaccine 2011, 29, 1634-1642.
37. Suzuki, K.; Hiroaki, H.; Kohda, D.; Tanaka, T. An isoleucine zipper peptide forms a native-like triple stranded coiled coil in solution. Protein Eng. 1998, 11, 1051-1055.
38. Kilgus, J.; Jardetzky, T.; Gorga, J.C.; Trzeciak, A.; Gillessen, D.; Sinigaglia, F. Analysis of the permissive association of a malaria T cell epitope with DR molecules. J. Immunol. 1991, 146, 307-315.
39. Sinigaglia, F.; Guttinger, M.; Kilgus, J.; Doran, D.M.; Matile, H.; Etlinger, H.; Trzeciak, A.; Gillessen, D.; Pink, J.R.L. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature 1988, 336, 778-780.
40. Senkovich, O.; Cook, W.J.; Mirza, S.; Hollingshead, S.K.; Protasevich, I.I.; Briles, D.E.; Chattopadhyay, D. Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein A provides insight into microbial defense mechanism. J. Mol. Biol. 2007, 370, 701-713.
41. Iannelli, F.; Oggioni, M.R.; Pozzi, G. Allelic variation in the highly polymorphic locus pspC of Streptococcus pneumoniae. Gene 2002, 284, 63-71.
42. Brown, S.; Santa Maria, J.P.; Walker, S. Wall Teichoic Acids of Gram-Positive Bacteria. Annu. Rev. Microbiol. 2013, 67, 313-336.
43. Percy, M.G.; Grundling, A. Lipoteichoic acid synthesis and function in gram-positive bacteria Annu. Rev. Microbiol. 2014, 68, 81-100.
44. Adzhubei, A.A.; Sternberg, M.J.E.; Makarov, A.A. Polyproline-II Helix in Proteins: Structure and Function. J. Mol. Biol. 2013, 425, 2100-2132.
45. Areschoug, T.; Linse, S.; Stalhammar-Carlemalm, M.; Heden, L.-O.; Lindahl, G. A Proline-Rich Region with a Highly Periodic Sequence in Streptococcal β Protein Adopts the Polyproline II Structure and Is Exposed on the Bacterial Surface. J. Bacteriol. 2002, 184, 6376-6383.
46. Bruckner, R.; Nuhn, M.; Reichmann, P.; Weber, B.; Hakenbeck, R. Mosaic genes and mosaic chromosomes-genomic variation in Streptococcus pneumoniae. Int. J. Med. Microbiol. 2004, 294, 157-168.